Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases - PubMed (original) (raw)
. 2006 Jan 13;281(2):1080-90.
doi: 10.1074/jbc.M509381200. Epub 2005 Nov 10.
Affiliations
- PMID: 16282325
- DOI: 10.1074/jbc.M509381200
Free article
Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases
Temesgen Samuel et al. J Biol Chem. 2006.
Free article
Abstract
Inhibitor of apoptosis proteins (IAPs) regulate apoptosis primarily by inhibiting caspase-family proteases. However, many IAPs also possess E3 ligase (ubiquitin-protein isopeptide ligase) activities implicated in both caspase-dependent and -independent functions of these proteins. Here, we compared the structural features of cIAP1 responsible for its interactions with two known target proteins, TRAF2 and SMAC. The N-terminal (BIR1) and C-terminal (BIR3) BIR domains of cIAP1 were determined to be necessary and sufficient for binding TRAF2 and SMAC, respectively. Mutational analysis of the BIR1 and BIR3 domains identified critical residues required for TRAF2 and SMAC binding. Using these mutants, cIAP1-mediated ubiquitination of TRAF2 and SMAC in vitro was determined to be correspondingly dependent on intact binding sites on BIR1 and BIR3. Because TRAF2 regulates NF-kappaB activation, the effects of cIAP1 on TRAF2-mediated induction of NF-kappaB transcriptional activity were studied using reporter gene assays. Expression of a fragment of cIAP1 encompassing the three BIR domains (but not full-length cIAP1) greatly enhanced TRAF2-induced increases in NF-kappaB activity, providing a convenient assay for monitoring BIR-dependent effects of cIAP1 on TRAF2 in cells. BIR1 mutants of the BIR1-3 fragment of cIAP1 that failed to bind TRAF2 lost the ability to modulate NF-kappaB activity, demonstrating a requirement for BIR1-mediated interactions with TRAF2. Altogether, these findings demonstrate the modularity and diversification of BIR domains, showing that a single cIAP can direct its E3 ligase activity toward different substrates and can alter the cellular functions of different protein targets in accordance with differences in the specificity of individual BIR domains.
Similar articles
- TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
Garrison JB, Samuel T, Reed JC. Garrison JB, et al. Oncogene. 2009 Apr 2;28(13):1584-93. doi: 10.1038/onc.2009.17. Epub 2009 Feb 23. Oncogene. 2009. PMID: 19234489 - Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.
Cossu F, Milani M, Vachette P, Malvezzi F, Grassi S, Lecis D, Delia D, Drago C, Seneci P, Bolognesi M, Mastrangelo E. Cossu F, et al. PLoS One. 2012;7(11):e49527. doi: 10.1371/journal.pone.0049527. Epub 2012 Nov 15. PLoS One. 2012. PMID: 23166698 Free PMC article. - The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
Varfolomeev E, Wayson SM, Dixit VM, Fairbrother WJ, Vucic D. Varfolomeev E, et al. J Biol Chem. 2006 Sep 29;281(39):29022-9. doi: 10.1074/jbc.M605116200. Epub 2006 Aug 4. J Biol Chem. 2006. PMID: 16891304 - TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.
Borghi A, Verstrepen L, Beyaert R. Borghi A, et al. Biochem Pharmacol. 2016 Sep 15;116:1-10. doi: 10.1016/j.bcp.2016.03.009. Epub 2016 Mar 16. Biochem Pharmacol. 2016. PMID: 26993379 Review. - Regulation of apoptosis proteins in cancer cells by ubiquitin.
Zhang HG, Wang J, Yang X, Hsu HC, Mountz JD. Zhang HG, et al. Oncogene. 2004 Mar 15;23(11):2009-15. doi: 10.1038/sj.onc.1207373. Oncogene. 2004. PMID: 15021888 Review.
Cited by
- Integrative Analyses of Transcriptome Sequencing Identify Functional miRNAs in the Chicken Embryo Fibroblasts Cells Infected With Reticuloendotheliosis Virus.
Zhai J, Gao C, Fu L, Jing L, Dang S, Zheng S. Zhai J, et al. Front Genet. 2018 Aug 29;9:340. doi: 10.3389/fgene.2018.00340. eCollection 2018. Front Genet. 2018. PMID: 30233638 Free PMC article. - Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.
Feltham R, Moulin M, Vince JE, Mace PD, Wong WW, Anderton H, Day CL, Vaux DL, Silke J. Feltham R, et al. J Biol Chem. 2010 Jun 4;285(23):17525-36. doi: 10.1074/jbc.M109.087635. Epub 2010 Mar 30. J Biol Chem. 2010. PMID: 20356846 Free PMC article. - Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy.
Lala-Tabbert N, Lejmi-Mrad R, Timusk K, Fukano M, Holbrook J, St-Jean M, LaCasse EC, Korneluk RG. Lala-Tabbert N, et al. Skelet Muscle. 2019 May 24;9(1):13. doi: 10.1186/s13395-019-0201-6. Skelet Muscle. 2019. PMID: 31126323 Free PMC article. - Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist.
Udompholkul P, Garza-Granados A, Alboreggia G, Baggio C, McGuire J, Pegan SD, Pellecchia M. Udompholkul P, et al. J Med Chem. 2023 Jun 22;66(12):8159-8169. doi: 10.1021/acs.jmedchem.3c00467. Epub 2023 Jun 1. J Med Chem. 2023. PMID: 37262387 Free PMC article. - Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.
Zheng C, Kabaleeswaran V, Wang Y, Cheng G, Wu H. Zheng C, et al. Mol Cell. 2010 Apr 9;38(1):101-13. doi: 10.1016/j.molcel.2010.03.009. Mol Cell. 2010. PMID: 20385093 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases